RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin .03 g/mL
AVOBENZONE, OCTISALATE, and OCTOCRYLENE · CREAM · ESTEE LAUDER INC
RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin is a cream containing avobenzone, octisalate, and octocrylene at .03 g/mL, taken topical. Manufactured by ESTEE LAUDER INC.
Key Facts
- Brand Name
- RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin
- Generic Name
- AVOBENZONE, OCTISALATE, and OCTOCRYLENE
- NDC Code (Product)
11559-053- Manufacturer
- ESTEE LAUDER INC
- Strength
- .03 g/mL
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- M020
- Marketing Start
- 12/01/2018
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Uses helps prevent sunburn if used as directed with other sun protection measures (see Directions ) decreases the risk of skin cancer and early skin aging caused by the sun
Dosage & Administration
Directions For sunscreen use: apply liberally and evenly 15 minutes before sun exposure reapply at least every two hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. – 2 p.m. wear long-sleeved shirts, pants, hats and sunglasses children under 6 months of age: ask a doctor
Warnings
Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Frequently Asked Questions
What is RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin used for?
RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin contains AVOBENZONE, OCTISALATE, and OCTOCRYLENE. It is a cream taken topical. Consult your doctor for specific uses.
Is RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin a controlled substance?
RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin is not classified as a controlled substance by the DEA.
What is the generic name for RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin?
The generic name for RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin is AVOBENZONE, OCTISALATE, and OCTOCRYLENE. There are 11 other brand versions of AVOBENZONE, OCTISALATE, and OCTOCRYLENE.
What is the NDC code for RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin .03 g/mL?
The NDC (National Drug Code) for RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 15 dry skin .03 g/mL is 11559-053, listed by ESTEE LAUDER INC.
Other Avobenzone, Brands
See all →- THE SPORTO Invisible Sport for Body30 mg/mL82757-204
- Kidspray Broad Spectrum Sunscreen SPF 4030 mg/mL49358-001
- Proactiv Clear Skin SPF 303 mg/100mL11410-073
- Olay Total Effects CC Tone Correcting Broad Spectrum SPF 15 Light to Medium2 g/mL37000-355
- Lancome Paris Renergie HPN 300 Peptide Sunscreen Broad Spectrum SPF 25 High-Performance Day30 mg/mL82046-054
- Lancome Paris Renergie HPN 300 Peptide Sunscreen Broad Spectrum SPF 25 High-Performance Day30 mg/mL51150-054
- RESILIENCE MULTI-EFFECT TRI-PEPTIDE FACE AND NECK CREME BROAD SPECTRUM SPF 1530 mg/mL11559-052
- Tint plus Tone SPF 50. SPF 50 Broad Spectrum Sunscreen Sheer Tinted Moisturizer30 mg/mL49358-582
- THE GOLDEN GUARD Browning Radiance Gel Suncare for Body30 mg/mL82757-202
- REVITALIZING SUPREME PLUS GLOBAL ANTI-AGING CELL POWER CREME BROAD SPECTRUM SPF 1530 mg/mL11559-056
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)